Thank you, Kelly. Welcome to the Aemetis's Second Quarter 2023 Earnings Review Conference Call. Joining us for the call today is Eric McAfee, Founder, Chairman and CEO of Aemetis; and Andy Foster, President of Aemetis Advanced Fuels and Aemetis Biogas. We suggest reading our website at aemetis.com to review today's earnings press release, the Aemetis Corporate and Investor Presentations, filings with the Securities and Exchange Commission, recent press releases and previous earnings conference calls. The presentation for the call today is available for review or download on the Investors section of aemetis.com website. Before we begin our discussion today, I'd like to read the following disclaimer statement. During today's call, we will be making forward-looking statements, including, without limitation, statements with respect to our future stock performance, plans, opportunities and expectations with respect to financing activities and the execution of our business plan. These statements must be considered in conjunction with the disclosures and cautionary warnings that appear in our SEC filings. Investors are cautioned that all forward-looking statements made on this call involve risks and uncertainties and that future events may differ materially from the statements made. For additional information, please refer to the company's Securities and Exchange Commission filings, which are posted on our website and are available from the company without charge. Our discussion on the call today will include a review of non-GAAP measures as a supplement to financial results based on GAAP because we believe these non-GAAP measures serve as a proxy for the company's sources or uses of cash during the periods presented. A reconciliation of non-GAAP measures to most directly comparable GAAP measures is included in our earnings release for the three and six months ended June 30, 2023 which is available on our website. Adjusted EBITDA is defined as net income or loss plus to the extent deducted in calculating such net income, interest expense, income tax expense, intangible and other amortization expense, accretion and other expenses of Series A preferred units, loss on lease termination, gain on litigation, depreciation expense and share-based compensation expense. Let's review the financial results for the second quarter of 2023. Revenues during the second quarter of 2023 were $45.1 million, compared to $65.9 million for the second quarter of 2022, principally driven by $33.6 million of sales from India Biodiesel. Our California ethanol operation restarted after an extended maintenance cycle, which allowed for the acceleration of the implementation of several important ethanol plant efficiency upgrades, allowing for the generation of $11.3 million of revenue during late May and June. Delivery corn price decreased significantly from an average price of $10.21 per bushel during the second quarter 2022 to $6.80 per bushel during the second quarter 2023. Gross profit for the second quarter of 2023 was $2 million, a significant improvement compared to a $214,000 gross loss during the second quarter of 2022. Selling, general and administrative expenses were $9.7 million during the second quarter of 2023, compared to $7.4 million during the second quarter of 2022. Including $1.3 million for fixed cost of goods sold that were allocated to selling, general and administrative expenses during the Keyes plant maintenance period. SG&A included $1.8 million of non-cash expense related to stock options and other considerations issued under stock incentive plans. Operating loss was $7.8 million and $7.7 million for each of the second quarter quarters of 2023 and 2022. Interest expense during the second quarter 2023 was $9.6 million, excluding accretion and other expense in connection with Series A preferred units in our Aemetis Biogas subsidiary, compared to $6.7 million during the second quarter 2022. Additionally, our Aemetis Biogas subsidiary recognized $6.9 million of accretion and other expenses in connection with preference payments on its preferred stock during the second quarter of 2023, compared to $1.5 million during the second quarter of 2022. Net loss was $25.3 million for the second quarter 2023, compared to a net loss of $209,000 for the second quarter of 2022, including the impact in 2022 of a grant of $14.2 million received from the United States Department of Agriculture Biofuel Producer Program and the release of a litigation reserve of $1.9 million. Our India plant contributed $5.1 million of adjusted EBITDA during the three months ended June 30, 2023, offset by adjusted EBITDA from the restart of the Keyes plant and other operations for a total company negative adjusted EBITDA of $4.2 million for the second quarter of 2023. Cash at the end of the quarter was $3.5 million, compared to $4.3 million at the close of 2022. This completes our review of the second quarter of 2023. During the first half of 2023, investments in capital projects were $9.8 million. Investments in capital projects related to Aemetis Biogas were $7.8 million. Investments in capital projects related to reduction of carbon intensity of Aemetis ethanol and other company initiatives were $2 million. Now I'd like to introduce the Founder, Chairman and Chief Executive Officer of Aemetis, Eric McAfee for a business update. Eric?